Nat Kellogg, CFA
President
Given the significant amount of volatility in the public markets and uncertainty surrounding the economic outlook as a result of the COVID-19 pandemic, this newsletter provides an update and outlook for private market investors.
This newsletter covers the valuation process used by private equity and debt funds, the expected impact on first quarter valuations for private market funds, how portfolios are positioned to handle the economic slowdown, what GPs are doing in this environment to protect and position their portfolio companies for the slowdown, and Marquette Associates’ outlook for the remainder of the year.
Read > What Does the COVID-19 Pandemic Mean for Private Equity Investments?
The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
04.23.2025
According to the most recent Bank of America Global Fund Manager Survey, gold has surged to the top of the…
04.17.2025
This video is a recording of a live webinar held April 16 by Marquette’s research team analyzing the first quarter…
04.16.2025
As markets swirl and stagflation fears mount, what should investors do? Our newsletter…
04.09.2025
Earlier this week, Marquette published a newsletter detailing the ongoing market volatility caused by the Trump administration’s…
04.07.2025
The global trade landscape has been significantly reshaped by a series of aggressive tariffs initiated by President Donald Trump. These…
04.01.2025
The first 100 days of a presidential administration are typically scrutinized closely as the public develops a sense of the…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >